Accumulation of renin and imidazolone in peritubular capillary endothelial cells in insulin-resistant hypertensive rats

Journal of Nephrology

Volumn 24, Issue 5, 2011, Pages 656-664

  Wagner, Zoltán ^a   Degrell, Péter ^a   Lukáts, Balázs ^b   Niwa, Toshimitsu ^c   Molnár, Gergo A ^a   Markó, Lajos ^a   Karádi, Zoltán ^b   Wittmann, István ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hypertension; Imidazolone; Impaired glucose tolerance; Peritubular capillary endothelial cells; Renin; Tubulointerstitial fibrosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; IMIDAZOLONE; RENIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIUM; ELECTRON MICROSCOPY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KIDNEY FIBROSIS; KIDNEY PAPILLA; KIDNEY TUBULE CELL; MALE; NONHUMAN; PERITUBULAR CAPILLARY ENDOTHELIAL CELL; RAT;

ANIMALS; BIOLOGICAL MARKERS; CAPILLARIES; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FIBROSIS; GLUCOSE INTOLERANCE; HYPERTENSION; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; KIDNEY DISEASES; KIDNEY TUBULES; MALE; MICROSCOPY, IMMUNOELECTRON; PYRUVALDEHYDE; RATS; RATS, WISTAR; RENIN;

EID: 80052678727     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.6520     Document Type: Article

References (29)

1. Rabelink TJ, Wijewickrama DC, de Koning EJ. Peritubular endothelium: the Achilles heel of the kidney? Kidney Int. 2007;72:926-930.
2. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Dia Med. 2002;19:708-723.
3. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52:2867-2873.
4. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251-287.
5. Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol. 2003;14:S254-S258.
6. Carey RM, Siragy HM. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab. 2003;14:274-281.
7. Zimpelmann J, Kumar D, Levine DZ, et al. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int. 2000;58:2320-2330.
8. Niwa T, Katsuzaki T, Miyazaki S, et al. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest. 1997;99:1272-1280.
9. Horie K, Miyata T, Maeda K, et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions: implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest. 1997;100:2995-3004.
10. Emonnot L, Cohen R, Lo M. Neonatal streptozotocininduced glucose intolerance: different consequences in Lyon normotensive and hypertensive rats. J Hypertens. 2007;25:429-438.
11. Axen KV, Li X, Fung K, Sciafani A. The VMH-dietary rat: a new model of non-insulin-dependent diabetes mellitus. Am J Physiol. 1994;266:R921-R928.
12. Karádi Z, Lukáts B. Papp Sz, Takács G, Egyed R, Lénárd L. The central glucose-monitoring neural network: major protector of the adaptive homeostatic balance for the well being of the organism. Int Congr Ser. 2004;1269:30-33.
13. Karádi Z, Lukáts B, Wittmann I, Degrell P, Kocsis B, Nagy J. Homeostatic alterations after methylglyoxal microinjection into the ventromedial hypothalamic nucleus of the rat. Neurobiology. 2001;9:206-207.
14. Pellegrino LJ, Pellegrino AS, Cushman AJ. A stereotaxic atlas of the rat brain. New York, NY: Plenum Press; 1979.
15. Lukáts B, Egyed R, Lénárd L, Karádi Z. Homeostatic alterations induced by interleukin-1beta microinjection into the orbitofrontal cortex in the rat. Appetite. 2005;45:137-147.
16. Niwa T, Miyazaki S, Katsuzaki T, et al. Immunohistochemical detection of advanced glycation end products in dialysisrelated amyloidosis. Kidney Int. 1995;48:771-778.
17. Fujita H, Narita T, Morii T, et al. Increased urinary excretion of N-acetylglucosaminidase in subjects with impaired glucose tolerance. Ren Fail. 2002;24:69-75.
18. Basturk T, Altuntaş Y, Kurklu A, Aydin L, Eren N, Unsal A. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/ indapamide combination. Ren Fail. 2006;28:125-128.
19. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease, more than an aftermath of glomerular injury? Kidney Int. 1999;56:1627-1637.
20. Lai KN, Leung JC, Lai KB, To WY, Yeung VT, Lai FM. Gene expression of the renin-angiotensin system in human kidney. J Hypertens. 1998;16:91-102.
21. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int. 1998;54:343-352.
22. Bendayan M. Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetes. Kidney Int. 1998;54:438-447.
23. Niwa T, Katsuzaki T, Ishizaki Y, et al. Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes. FEBS Lett. 1997;407:297-302.
24. Boor P, Šebeková K, Ostendorf T, Floege J. Treatment targets in renal fibrosis. Nephrol Dial Transplant. 2007;22:3391-3407.
25. Mathiesen ER, Hommel E, Hansen HP, Smidt UM, Parving HH. Randomized controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria. BMJ. 1999;319:24-25.
26. Oldfield MD, Bach LA, Forbes JM, et al. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest. 2001;108:1853-1863.
27. Thomas MC, Tikellis C, Burns WM, et al. Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol. 2005;16:2976-2984.
28. Burns KD, Homma T, Harris RC. The intrarenal renin-angiotensin system. Semin Nephrol. 1993;13:13-30.
29. Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol. 2005;289:F645-F659.